Comparison of the anti-neoplastic effects of dirhodium(II) tetrapropionate and its adducts with nicotinate and isonicotinate anions in mice bearing Ehrlich tumors

European Journal of Medicinal Chemistry

Volumn 41, Issue 10, 2006, Pages 1214-1216

  de Souza, Aparecido Ribeiro ^a   Coelho, Eliel Pereira ^a   Zyngier, Szulim Ber ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti tumor; Carboxylate; Ehrlich tumors; Rhodium

Indexed keywords

ANTINEOPLASTIC AGENT; DIRHODIUM TETRAPROPIONATE; ISONICOTINIC ACID; NICOTINIC ACID; RHODIUM DERIVATIVE; UNCLASSIFIED DRUG; ANION; ORGANOMETALLIC COMPOUND; PROPIONIC ACID DERIVATIVE; RHODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; FEMALE; MANTEL HAENSZEL TEST; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; PROBABILITY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; ANIMAL; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; SYNTHESIS;

ANIMALS; ANIONS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; ISONICOTINIC ACIDS; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; NIACIN; ORGANOMETALLIC COMPOUNDS; PROPIONATES; RHODIUM; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33749630816     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.05.016     Document Type: Article

References (15)

1. Zhang C.X., and Lippard S.J. New metal complexes as potential therapeutics. Curr. Opin. Chem. Biol. 7 4 (2003) 481-489
2. Hughes R.G., Bear J.L., and Kimball A.P. Proc. Am. Assoc. Cancer Res. 13 (1972) 120
3. Erck A., Rainen L., Whileyman J., Chang I.M., Kimball A.P., and Bear J. Studies of rhodium(II) carboxylates as potential antitumor agents. Proc. Soc. Exp. Bio. Med. 145 4 (1974) 1278-1283
4. Bear J.L. Precious metals 1985. In: Zysk E.E., and Bonucci J.A. (Eds). Proceedings of the ninth international precious metals conference (1986), Int Precious Metals, Allentown, PA
5. 4: the first biological assays of a rhodium(II) amidate. Met. Based Drugs 4 (1997) 333-338
6. Katsaros N., and Anagnostopoulou A. Rhodium and its compounds as potential agents in cancer treatment. Crit. Rev. Oncol. Hematol. 42 3 (2002) 297-308
7. Chifotides H.T., and Dunbar K. Interactions of Metal-Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNA. Acc. Chem. Res. 38 (2005) 146-156
8. 2. Polyhedron 24 12 (2005) 1577-1584
9. Howard R.A., Sherwood E., Erck A., Kimball A.P., and Bear J.L. Hydrophobicity of several rhodium(II) carboxylates correlated with their biologic activity. J. Med. Chem. 20 7 (1977) 943-946
10. Rao P.N., Smith M.L., Pathak S., Howard R.A., and Bear J.L. Rhodium(II) butyrate: a potential anticancer drug with cell cycle phase specific effects in HeLa cells. J. Natl. Cancer Inst. 64 (1980) 905-912
11. Najjar R., Santos F.S., and Seidel W. Synthesis and characterization of the Rh(II) citrate complex. An. Acad. Bras. Cienc. 59 (1987) 13-16
12. Gil E.S., Gonçalves M.I.A., Ferreira E.I., Zyngier S.B., and Najjar R. Water soluble cyclophosphamide adducts of rhodium(II) keto-gluconate and glucuronate. Synthesis, characterization and in vitro cytostatic assays. Met. Based Drugs 6 (1999) 19-24
13. Nothenberg M.S., Souza A.R., and Matos J.R. Synthesis and physicochemical characterization of rhodium sulfosalicylate. Polyhedron 19 (2000) 1305-1309
14. Sinistera R.D., Shastri V.P., Najjar R., and Langer R. Encapsulation and release of rhodium(II) citrate and its association with hydroxypropyl-β-cyclodextrin from biodegradable polymer microspheres. J. Pharm. Sci. 88 5 (1999) 574-576
15. de Souza A.R., Najjar R., Glikmanas S., and Zyngier S.B. Water-soluble rhodium(II) carboxylate: cytotoxicity of the new compounds. J. Inorg. Biochem. 64 (1996) 1-5